• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子对接方法探索[具体内容]在新型冠状病毒(COVID-19)干预中的活性成分。 (你提供的原文中“Exploring the active constituents of ”后面缺少具体物质,我按正常翻译思路补齐了这部分内容的中文表述方式,实际使用时请根据完整准确的原文进行调整。)

Exploring the active constituents of in intervention of novel coronavirus (COVID-19) based on molecular docking method.

作者信息

Shah Sapan, Chaple Dinesh, Arora Sumit, Yende Subhash, Moharir Keshav, Lohiya Govind

机构信息

Department of Pharmaceutical Chemistry, Priyadarshini J. L. College of Pharmacy, Hingna Road, Nagpur, Maharashtra 440016 India.

Pharmacognosy and Phytochemistry Division, Gurunanak College of Pharmacy, Nari, Nagpur, Maharashtra 440026 India.

出版信息

Netw Model Anal Health Inform Bioinform. 2021;10(1):8. doi: 10.1007/s13721-020-00279-y. Epub 2021 Feb 6.

DOI:10.1007/s13721-020-00279-y
PMID:33585155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865104/
Abstract

UNLABELLED

The severe acute respiratory syndrome COVID-19 declared a global pandemic by WHO has become the present wellbeing worry to the whole world. There is an emergent need to search for possible medications. We report in this study a molecular docking study of eighteen molecules with the main protease (M) responsible for the replication of SARS-CoV-2 virus. The outcome of their molecular simulation and ADMET properties reveal four potential inhibitors of the enzyme (Baicalein-7--diglucoside, Chrysin-7--glucuronide, Oroxindin and Scutellarein) with preference of ligand Chrysin-7--glucuronide that has the second highest binding energy (- 8.6 kcal/mol) and fully obeys the Lipinski's rule of five.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13721-020-00279-y.

摘要

未标注

世界卫生组织宣布的严重急性呼吸综合征冠状病毒2(COVID-19)已成为全球目前对健康的担忧。迫切需要寻找可能的药物。我们在本研究中报告了18种分子与负责严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒复制的主要蛋白酶(M)的分子对接研究。它们的分子模拟和药物代谢动力学(ADMET)性质的结果揭示了该酶的四种潜在抑制剂(黄芩苷-7-O-二葡萄糖苷、白杨素-7-O-葡萄糖醛酸苷、oroxindin和黄芩素),其中配体白杨素-7-O-葡萄糖醛酸苷具有第二高的结合能(-8.6千卡/摩尔)且完全符合Lipinski的五规则。

补充信息

在线版本包含可在10.1007/s13721-020-00279-y获取的补充材料。

相似文献

1
Exploring the active constituents of in intervention of novel coronavirus (COVID-19) based on molecular docking method.基于分子对接方法探索[具体内容]在新型冠状病毒(COVID-19)干预中的活性成分。 (你提供的原文中“Exploring the active constituents of ”后面缺少具体物质,我按正常翻译思路补齐了这部分内容的中文表述方式,实际使用时请根据完整准确的原文进行调整。)
Netw Model Anal Health Inform Bioinform. 2021;10(1):8. doi: 10.1007/s13721-020-00279-y. Epub 2021 Feb 6.
2
Anticancer potential of phytochemicals from targeting Lactate Dehydrogenase A through bioinformatic approach.通过生物信息学方法靶向乳酸脱氢酶A的植物化学物质的抗癌潜力。
Toxicol Rep. 2022 Dec 14;10:56-75. doi: 10.1016/j.toxrep.2022.12.007. eCollection 2023.
3
Identification of potential inhibitors of SARS-CoV-2 main protease from compounds: A molecular docking study.从化合物中鉴定严重急性呼吸综合征冠状病毒2主要蛋白酶的潜在抑制剂:一项分子对接研究。
Chem Phys Lett. 2020 Sep;754:137751. doi: 10.1016/j.cplett.2020.137751. Epub 2020 Jun 30.
4
In-silico evaluation of Oroxylum indicum vent compounds in the plausible treatment and prevention of nasopharyngeal cancer.对木蝴蝶属植物化合物在鼻咽癌合理治疗与预防中的计算机模拟评估。
J Ayurveda Integr Med. 2024 May-Jun;15(3):100986. doi: 10.1016/j.jaim.2024.100986. Epub 2024 May 27.
5
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物( Ashwagandha )、( Giloy )和( Tulsi )的活性植物化学成分靶向 COVID-19 ( SARS-CoV-2 )主蛋白酶 - ( Ashwagandha )、( Giloy )和( Tulsi ) - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
6
An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT exploration.一些新型螺环-N-(4-氨磺酰基苯基)-1,3,4-噻二唑-2-甲酰胺衍生物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白酶潜在抑制剂的高效、环保、简单且绿色的合成:类药性、药效团、分子对接及密度泛函理论研究
Mol Divers. 2024 Feb;28(1):249-270. doi: 10.1007/s11030-023-10761-0. Epub 2023 Nov 9.
7
Prospecting for to treat COVID-19 via molecular docking models of the SARS-CoV-2.通过 SARS-CoV-2 的分子对接模型寻找治疗 COVID-19 的药物。
J Biomol Struct Dyn. 2022 Aug;40(12):5643-5652. doi: 10.1080/07391102.2021.1872419. Epub 2021 Jan 15.
8
A Review on the Taxonomy, Ethnobotany, Chemistry and Pharmacology of Oroxylum indicum Vent.对木蝴蝶的分类学、民族植物学、化学和药理学的综述
Indian J Pharm Sci. 2011 Sep;73(5):483-90. doi: 10.4103/0250-474X.98981.
9
Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease.昆虫蛋白酶抑制剂;有望抑制 SARS-CoV-2 主蛋白酶的化合物。
Comput Biol Med. 2022 Mar;142:105228. doi: 10.1016/j.compbiomed.2022.105228. Epub 2022 Jan 13.
10
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.

引用本文的文献

1
Network pharmacology and in-silico studies for molecular mechanisms of analgesic, anti-inflammatory and anti-arthritic effects of Withania somnifera (L.) Dunal phytoconstituents.睡茄植物成分镇痛、抗炎和抗关节炎作用分子机制的网络药理学及计算机模拟研究
J Ayurveda Integr Med. 2025 Jun 26;16(4):101088. doi: 10.1016/j.jaim.2024.101088.
2
Plants used in Ayurveda for Jwara or fever: A review of their antiviral studies.阿育吠陀医学中用于治疗发热的植物:其抗病毒研究综述
J Ayurveda Integr Med. 2025 Mar-Apr;16(2):101085. doi: 10.1016/j.jaim.2024.101085. Epub 2025 Apr 30.
3
Phytomedicines explored under and studies against coronavirus: An opportunity to develop traditional medicines.

本文引用的文献

1
Natural products' role against COVID-19.天然产物在抗击新冠病毒中的作用。
RSC Adv. 2020 Jun 19;10(39):23379-23393. doi: 10.1039/d0ra03774e. eCollection 2020 Jun 16.
2
Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.新型冠状病毒 SARS-CoV-2 的分子机制以及大流行爆发以来潜在的抗 COVID19 药理学靶点。
Food Chem Toxicol. 2020 Dec;146:111805. doi: 10.1016/j.fct.2020.111805. Epub 2020 Oct 8.
3
Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS.
在[具体研究条件1]和[具体研究条件2]下探索的抗冠状病毒植物药:开发传统药物的契机。
S Afr J Bot. 2022 Dec;151:451-483. doi: 10.1016/j.sajb.2022.04.053. Epub 2022 May 2.
4
Insight into OroxylinA-7--β-d-Glucuronide-Enriched Bark Extract in Oral Cancer HSC-3 Cell Apoptotic Mechanism: Role of Mitochondrial Microenvironment.解析胡黄连苷 A-7-β-D-葡萄糖醛酸苷富集树皮提取物诱导口腔癌细胞 HSC-3 凋亡的机制:线粒体微环境的作用。
Molecules. 2021 Dec 7;26(24):7430. doi: 10.3390/molecules26247430.
易感性还是保护性?:一名接受左心室辅助装置支持且感染艾滋病毒/艾滋病的患者的新冠肺炎情况
JACC Case Rep. 2020 Jul 15;2(9):1337-1341. doi: 10.1016/j.jaccas.2020.05.015. Epub 2020 May 19.
4
The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?草药和天然化合物的抗病毒及抑制冠状病毒与宿主蛋白相互作用途径的特性——对抗新冠疫情的额外武器?
J Tradit Complement Med. 2020 May 30;10(4):405-419. doi: 10.1016/j.jtcme.2020.05.003. eCollection 2020 Jul.
5
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.体外评估单药和联合再利用药物抗 SARS-CoV-2 的抗病毒活性。
Antiviral Res. 2020 Sep;181:104878. doi: 10.1016/j.antiviral.2020.104878. Epub 2020 Jul 15.
6
In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein.对卡巴萨鲁库迪内尔(官方悉达配方)和JACOM针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白进行计算机模拟计算筛选。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100324. doi: 10.1016/j.jaim.2020.05.009. Epub 2020 May 25.
7
Current status of potential therapeutic candidates for the COVID-19 crisis.当前应对 COVID-19 危机的潜在治疗候选药物的现状。
Brain Behav Immun. 2020 Jul;87:59-73. doi: 10.1016/j.bbi.2020.04.046. Epub 2020 Apr 22.
8
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.通过计算方法分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的治疗靶点并发现潜在药物
Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27.
9
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.基于现有证据对 2019 年新型冠状病毒(SARS-CoV-2)的回顾。
Int J Antimicrob Agents. 2020 Jun;55(6):105948. doi: 10.1016/j.ijantimicag.2020.105948. Epub 2020 Mar 19.
10
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.